Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 17/20 | 0.82 |
| ▸ | CTNNB1 | P35222 | 17/20 | 0.82 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.41 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.41 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.41 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.41 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.41 |
| ▸ | MET | P08581 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18152394 | 0.97 | BCL9 (0.82) | BCL9CTNNB1KCNQ3KCNQ2KCNE1 | |
| SCHEMBL18152388 | 0.92 | CTNNB1 (0.81) | BCL9CTNNB1 | |
| SCHEMBL18152329 | 0.92 | BCL9 (0.79) | BCL9CTNNB1MET | |
| SCHEMBL18165095 | 0.91 | BCL9 (0.98) | BCL9CTNNB1KCNQ3KCNQ2KCNE1 | |
| SCHEMBL18152471 | 0.90 | BCL9 (0.82) | BCL9CTNNB1 | |
| SCHEMBL18165094 | 0.89 | BCL9 (0.98) | BCL9CTNNB1KCNQ3KCNQ2KCNE1 | |
| SCHEMBL18152447 | 0.84 | BCL9 (0.81) | BCL9CTNNB1MET | |
| SCHEMBL18165096 | 0.83 | BCL9 (0.98) | BCL9CTNNB1MET | |
| SCHEMBL18165097 | 0.83 | CTNNB1 (0.98) | BCL9CTNNB1 | |
| SCHEMBL20021893 | 0.82 | BCL9 (0.85) | BCL9CTNNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016168524-A1 | SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2016-10-20 | — | — | WO | disclosed |